Status:
RECRUITING
Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy
Lead Sponsor:
South Valley University
Conditions:
Type 2 Diabetes Mellitus
Peripheral Neuropathy
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
The investigators initial study opened the way for randomized trials that monitor the effects of acetylcholine (Ach) iontophoresis vasodilators on endothelial nitric oxide synthetase (NOS) to develop ...
Detailed Description
The investigators studied endothelial-mediated microvascular blood flow in neuropathic diabetic patients to determine the association between endothelial regulation of the microcirculation and the exp...
Eligibility Criteria
Inclusion
- Patients have to be symptomatically stable with type 2 diabetes mellitus complicated with peripheral neuropathy.
- Optimized pharmacological treatment that will be remained unchanged throughout the study.
Exclusion
- Implanted cardiac pacemakers.
- Patients with known skin allergies.
- Presence of skin inflammations.
- Peripheral vascular disease.
Key Trial Info
Start Date :
October 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06219590
Start Date
October 28 2023
End Date
January 30 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Physical Therapy, South Valley University
Qina, Egypt, 83523